CONTACT US

*Category

Required

*Name

Required

*Title

Required

Company

Company Type

*Country/Area

Required

*Tel

Required

*Email

Required

Job Title

*Message

Required

*Verification

Required

AmCad BioMed Corporation

+886-2-2713-6227

marketing@amcadbiomed.com

Fl.5-2, No. 167, Fu Hsing N. RD. Taipei 105, Taiwan

Obstructive sleep apnea is a potentially serious sleep disorder. It causes breathing to repeatedly stop and start during sleep.

MULTIPLE RISKS OF UNTREATED OBSTRUCTIVE SLEEP APNEA

80% Undiagnosed

OSA affects up to 20% of the world population and it is estimated that 80% of potential cases are undiagnosed.

Current Detection Methods

The most common detection method is polysomnography, which suffers from a number of disadvantages

  • PSG requires overnight testing at a sleep center or static location.

  • Patients can wait up to 6 months for PSG at a sleep center.

  • Uncomfortable overnight stay affects the quality of sleep.

  • Simple tossing and turning during sleep can loosen electrode patches and affect signals

AmCAD-UO OSA DETECTION

AmCAD-UO offers 10-minute detection for obstructive sleep apnea on awake patients, helping doctors to evaluate the root cause of sleep apnea and offer assessment for moderate/severe OSA patients. With laser-guided positioning, AmCAD-UO can precisely scan upper airway and analyze the gap between normal breathing and Müller Maneuver models. AmCAD-UO system standardizes ultrasound transducer scanning to reduce intra-observer variations and make the assessment consistent.

Clinical Workflow
Click to try it!
Click to try it!

Laser-Guided Positioning

Automated Scan for
Normal Breathing and
Müller Maneuver

Patient Information

Collect and analyze
ultrasound images

Detection Report

Moderate & Severe
OSA Assessment

Current Treatments Challenges

Effectiveness is difficult to evaluate for different OSA treatments leading to low compliance rate Noncompliance rate up to 68%

  • CPAP

  • Oral Appliance

  • OSA Surgery

  • Hypoglossal Nerve Stimulation

AmCAD-UO Companion Diagnostics

Immediate 3D Anatomic Airway Assessment for Treatment Evaluation

Copyright © 2019 AmCad BioMed Corporation. All Rights Reserved. Web Design- rIDEA